QT
ORTX

Quantbot Technologies’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Quantbot Technologies’s Portfolio ORTX Stock Details ORTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-330
Closed -$2K – 2251
2022
Q1 		$2K Hold
330
– – ﹤0.01% 1573
2021
Q4 		$4K Hold
330
– – ﹤0.01% 1402
2021
Q3 		$7K Buy
+330
New +$9.82K ﹤0.01% 1389

Other funds holding ORTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Quantbot Technologies's ORTX Position: Q2 2022 in Review

Quantbot Technologies sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q2 2022, closing a stake of 330 shares — an estimated $2K sold.

Quantbot Technologies first reported a position in ORTX in Q3 2021 and held it in 3 quarters. The position peaked at $7K in Q3 2021. 50 funds tracked by Wall St. Rank hold ORTX as of Q2 2022.

  • Quantbot Technologies reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q2 2022 after selling out during the quarter.
  • Quantbot Technologies sold 330 Orchard Therapeutics plc American Depositary Shares shares in Q2 2022, an estimated $2K.
  • Quantbot Technologies first reported a position in Orchard Therapeutics plc American Depositary Shares in Q3 2021 and held it in 3 quarters.
  • Quantbot Technologies's Orchard Therapeutics plc American Depositary Shares position peaked at $7K in Q3 2021.
  • 50 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q2 2022.

Based on Quantbot Technologies's 13F filing for Q2 2022, filed 9 Aug 2022.